Ovarian Tumors of Low Malignant Potential

Executive Summary Ovarian tumors of low malignant potential can be a challenge in daily underwriting, as even clinicians are not in full agreement about the correct approach. This article sheds light on this tumor and highlights some of the key favorable factors when underwriting this condition. INTRODUCTION Ovarian tumors of low malignant potential, also known as borderline tumors of the ovary, account for roughly 15% of all primary epithelial ovarian tumors1. For years, experts held differing opinions as to whether these tumors are benign, semi-malignant or malignant. While there continues to be some controversy regarding these borderline tumors, most experts agree that borderline tumors are their own entity of ovarian tumors as their behavior is quite different from ovarian carcinoma. These tumors are now classifi ed as having low malignant potential, as microinvasion and transformation to a true invasive ovarian cancer, especially at late stages, is possible but unlikely.